Floatz logo

CALCIUM FOLATE

Colon Cancer

Wyeth is now a wholly owned subsidiary of PfizerSmall moleculePhase 3Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
65/ 100

Competitive context

128 Active assets in the Colon Cancer cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Akeso
Phase 4BB
Eloxatin
Sun Yat-sen University
Phase 3BB
Calcium folinate pentahydrate
Akeso
Phase 3BB
Irinotecan
SCRI Development Innovations, LLC
Phase 3BB
MACROGOLS
University Medical Center Ho Chi Minh City (UMC)
Phase 4BB

View all 50 →

Same molecule, other indications

CALCIUM FOLATE is also rated in:

colorectal cancerDormant
BB
Indicative ·
66 / 100
View asset →
Non-small Cell Lung CancerDormant
CCC
Indicative ·
50 / 100
View asset →
Poststroke/CVA HemiparesisDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →